Wernicke-Korsakoff syndrome: Difference between revisions
Ostermayer (talk | contribs) No edit summary |
(Formatting: removed bold) |
||
| Line 14: | Line 14: | ||
===Pathophysiology=== | ===Pathophysiology=== | ||
*Thiamine (vitamin B1) is a cofactor for enzymes critical to cerebral energy metabolism: | *Thiamine (vitamin B1) is a cofactor for enzymes critical to cerebral energy metabolism: | ||
** | **Energy production pathways: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase (Krebs cycle, pentose phosphate pathway) | ||
***Deficiency leads to impaired ATP production → [[lactic acidosis]], neuronal/astrocytic injury, and altered brain metabolism | ***Deficiency leads to impaired ATP production → [[lactic acidosis]], neuronal/astrocytic injury, and altered brain metabolism | ||
***Brain regions with high metabolic demand are most vulnerable | ***Brain regions with high metabolic demand are most vulnerable | ||
** | **Lipid metabolism (including myelin sheath formation) | ||
***Alterations in myelination leads to peripheral neuropathy | ***Alterations in myelination leads to peripheral neuropathy | ||
*Thiamine half-life is only ~96 minutes; body stores are depleted within 2-3 weeks without intake | *Thiamine half-life is only ~96 minutes; body stores are depleted within 2-3 weeks without intake | ||
| Line 31: | Line 31: | ||
===Causes=== | ===Causes=== | ||
*Thiamine (vitamin B1) deficiency caused by: | *Thiamine (vitamin B1) deficiency caused by: | ||
** | **Insufficient intake | ||
***Chronic [[alcoholism]] (most common cause in Western countries) | ***Chronic [[alcoholism]] (most common cause in Western countries) | ||
***Starvation/[[anorexia]]/eating disorders | ***Starvation/[[anorexia]]/eating disorders | ||
| Line 37: | Line 37: | ||
***Unbalanced or thiamine-deficient TPN | ***Unbalanced or thiamine-deficient TPN | ||
***Self-imposed dietary restriction | ***Self-imposed dietary restriction | ||
** | **Malabsorption | ||
***Post-bariatric surgery (especially Roux-en-Y gastric bypass) | ***Post-bariatric surgery (especially Roux-en-Y gastric bypass) | ||
***Post-gastrectomy | ***Post-gastrectomy | ||
| Line 43: | Line 43: | ||
***[[Pancreatitis]] | ***[[Pancreatitis]] | ||
***Intestinal obstruction | ***Intestinal obstruction | ||
** | **Increased metabolic requirements | ||
***Malignancy/cancer chemotherapy | ***Malignancy/cancer chemotherapy | ||
***[[Thyrotoxicosis]] | ***[[Thyrotoxicosis]] | ||
| Line 49: | Line 49: | ||
***Refeeding syndrome | ***Refeeding syndrome | ||
***Carbohydrate loading (iatrogenic — can unmask subclinical deficiency) | ***Carbohydrate loading (iatrogenic — can unmask subclinical deficiency) | ||
** | **Thiamine losses | ||
***[[Hemodialysis]]/peritoneal dialysis | ***[[Hemodialysis]]/peritoneal dialysis | ||
** | **Miscellaneous: [[AIDS]], chronic liver disease, prolonged ICU admission, magnesium depletion (magnesium is a cofactor for thiamine-dependent enzymes) | ||
{{Thiamine deficiency types}} | {{Thiamine deficiency types}} | ||
| Line 57: | Line 57: | ||
===Wernicke's Encephalopathy=== | ===Wernicke's Encephalopathy=== | ||
*Classic triad: [[encephalopathy]], oculomotor dysfunction, gait [[ataxia]] | *Classic triad: [[encephalopathy]], oculomotor dysfunction, gait [[ataxia]] | ||
** | **Classic triad present in only ~10% of cases — do NOT rely on complete triad to make diagnosis | ||
*wer'''NIC'''ke mnemonic: | *wer'''NIC'''ke mnemonic: | ||
**[[nystagmus|'''N'''ystagmus]]/ophthalmoplegia | **[[nystagmus|'''N'''ystagmus]]/ophthalmoplegia | ||
| Line 63: | Line 63: | ||
***Other ocular findings: bilateral 6th nerve palsy, conjugate gaze palsy, pupillary abnormality, retinal hemorrhage, ptosis | ***Other ocular findings: bilateral 6th nerve palsy, conjugate gaze palsy, pupillary abnormality, retinal hemorrhage, ptosis | ||
***May progress to complete ophthalmoplegia | ***May progress to complete ophthalmoplegia | ||
** | **Incoordination/[[ataxia]] | ||
***Legs affected more than arms (vestibular + cerebellar dysfunction) | ***Legs affected more than arms (vestibular + cerebellar dysfunction) | ||
***Primarily affects gait; arms and speech usually spared | ***Primarily affects gait; arms and speech usually spared | ||
| Line 119: | Line 119: | ||
===Imaging=== | ===Imaging=== | ||
* | *CT head: sensitivity only ~13% for WE; primary role is to exclude other pathology (hemorrhage, mass, infarct)<ref>Medscape. Wernicke Encephalopathy Workup. Available at: https://emedicine.medscape.com/article/794583-workup</ref> | ||
* | *MRI brain (best imaging modality if obtained): | ||
**Sensitivity ~53%, specificity ~93%, positive predictive value ~89% | **Sensitivity ~53%, specificity ~93%, positive predictive value ~89% | ||
***MRI is better at '''confirming''' the diagnosis than '''ruling it out''' | ***MRI is better at '''confirming''' the diagnosis than '''ruling it out''' | ||
| Line 135: | Line 135: | ||
===Diagnosis=== | ===Diagnosis=== | ||
* | *Clinical diagnosis — maintain high index of suspicion | ||
* | *Caine criteria (operational diagnostic criteria; ~85% sensitive when ≥2 present)<ref>Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51-60.</ref>: | ||
**Nutritional deficiency (any state, not just alcoholism) | **Nutritional deficiency (any state, not just alcoholism) | ||
**Ocular findings (ophthalmoplegia, nystagmus) | **Ocular findings (ophthalmoplegia, nystagmus) | ||
| Line 151: | Line 151: | ||
===Acute Treatment=== | ===Acute Treatment=== | ||
* | *[[Thiamine]] — '''IV administration is critical; oral absorption is unreliable in at-risk patients''' | ||
**Royal College of Physicians / UK guideline (widely adopted): | **Royal College of Physicians / UK guideline (widely adopted): | ||
*** | ***500 mg IV over 30 min TID x 2-3 days → then 250 mg IV/IM once daily x 3-5 days → then 100 mg PO daily until patient no longer at risk | ||
**EFNS guideline: | **EFNS guideline: | ||
***200 mg IV TID (diluted in 100 mL NS or D5W, infused over 30 min) | ***200 mg IV TID (diluted in 100 mL NS or D5W, infused over 30 min) | ||
** | **100 mg/day (e.g., banana bag dose) is likely insufficient — especially in patients with alcohol use disorder | ||
**Thiamine has a short half-life (~96 min); multiple daily doses are more effective than once-daily dosing | **Thiamine has a short half-life (~96 min); multiple daily doses are more effective than once-daily dosing | ||
**Overall safety of thiamine is very good; anaphylaxis risk with IV thiamine is rare | **Overall safety of thiamine is very good; anaphylaxis risk with IV thiamine is rare | ||
===Key Principles=== | ===Key Principles=== | ||
* | *Give thiamine BEFORE glucose in any at-risk patient requiring dextrose | ||
**Glucose without thiamine can precipitate or worsen WE by driving remaining thiamine intracellularly | **Glucose without thiamine can precipitate or worsen WE by driving remaining thiamine intracellularly | ||
**If both are urgently needed (e.g., symptomatic hypoglycemia), give them simultaneously — do not withhold glucose to wait for thiamine | **If both are urgently needed (e.g., symptomatic hypoglycemia), give them simultaneously — do not withhold glucose to wait for thiamine | ||
* | *Give [[magnesium]] | ||
**Magnesium is a cofactor for thiamine-dependent enzymes | **Magnesium is a cofactor for thiamine-dependent enzymes | ||
**Hypomagnesemia may cause resistance to thiamine therapy | **Hypomagnesemia may cause resistance to thiamine therapy | ||
| Line 199: | Line 199: | ||
==Disposition== | ==Disposition== | ||
* | *Admit (inpatient medicine or neurology service) | ||
**Ensures continued IV thiamine and magnesium administration | **Ensures continued IV thiamine and magnesium administration | ||
**Observation for development of Korsakoff syndrome | **Observation for development of Korsakoff syndrome | ||
Revision as of 16:17, 19 March 2026
Background
- Wernicke's Encephalopathy (WE): acute neurologic syndrome caused by thiamine deficiency
- Korsakoff's Psychosis (KS): chronic neuropsychiatric syndrome caused by thiamine deficiency
- Wernicke-Korsakoff Syndrome (WKS): presence of Wernicke's Encephalopathy + Korsakoff's Psychosis simultaneously
- First described by Carl Wernicke in 1881; remains one of the most underdiagnosed and undertreated neurologic emergencies
Epidemiology
- Autopsy prevalence ~2% in the general population; up to 12.5% in patients with alcohol use disorder[1]
- Only ~20% of cases are identified before death; failure of diagnosis leads to ~20% mortality and ~75% permanent neurologic damage
- Classic triad (encephalopathy, oculomotor dysfunction, ataxia) is present in only ~10% of patients[2]
- ~80% of patients with untreated WE progress to Korsakoff syndrome
- Not limited to alcoholics — increasingly recognized post-bariatric surgery (~10% prevalence), in hyperemesis gravidarum, cancer, and critically ill patients
Pathophysiology
- Thiamine (vitamin B1) is a cofactor for enzymes critical to cerebral energy metabolism:
- Energy production pathways: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase (Krebs cycle, pentose phosphate pathway)
- Deficiency leads to impaired ATP production → lactic acidosis, neuronal/astrocytic injury, and altered brain metabolism
- Brain regions with high metabolic demand are most vulnerable
- Lipid metabolism (including myelin sheath formation)
- Alterations in myelination leads to peripheral neuropathy
- Energy production pathways: pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase, transketolase (Krebs cycle, pentose phosphate pathway)
- Thiamine half-life is only ~96 minutes; body stores are depleted within 2-3 weeks without intake
- Brain lesions/atrophy usually occur in (bilateral, symmetric):
- Mammillary bodies (nearly all cases — involvement is pathognomonic)
- Medial thalamus
- Periaqueductal gray matter
- 3rd/4th ventricle walls
- Tectal plate
- Cerebellum (especially vermis)
- Frontal lobe (atypical)
Causes
- Thiamine (vitamin B1) deficiency caused by:
- Insufficient intake
- Chronic alcoholism (most common cause in Western countries)
- Starvation/anorexia/eating disorders
- Severe vomiting/diarrhea/hyperemesis gravidarum
- Unbalanced or thiamine-deficient TPN
- Self-imposed dietary restriction
- Malabsorption
- Post-bariatric surgery (especially Roux-en-Y gastric bypass)
- Post-gastrectomy
- IBD, celiac disease
- Pancreatitis
- Intestinal obstruction
- Increased metabolic requirements
- Malignancy/cancer chemotherapy
- Thyrotoxicosis
- Sepsis, critical illness
- Refeeding syndrome
- Carbohydrate loading (iatrogenic — can unmask subclinical deficiency)
- Thiamine losses
- Hemodialysis/peritoneal dialysis
- Miscellaneous: AIDS, chronic liver disease, prolonged ICU admission, magnesium depletion (magnesium is a cofactor for thiamine-dependent enzymes)
- Insufficient intake
Thiamine deficiency types
Clinical Features
Wernicke's Encephalopathy
- Classic triad: encephalopathy, oculomotor dysfunction, gait ataxia
- Classic triad present in only ~10% of cases — do NOT rely on complete triad to make diagnosis
- werNICke mnemonic:
- Nystagmus/ophthalmoplegia
- Horizontal nystagmus is the most common ocular finding (not complete ophthalmoplegia)
- Other ocular findings: bilateral 6th nerve palsy, conjugate gaze palsy, pupillary abnormality, retinal hemorrhage, ptosis
- May progress to complete ophthalmoplegia
- Incoordination/ataxia
- Legs affected more than arms (vestibular + cerebellar dysfunction)
- Primarily affects gait; arms and speech usually spared
- Confusion/memory impairment
- Delirium/encephalopathy is the most consistent clinical feature
- May present as apathy, inattention, disorientation, or progress to coma
- Nystagmus/ophthalmoplegia
- Other symptoms:
- Hypotension, tachycardia, ECG abnormalities
- Dyspnea on exertion, CHF symptoms (cardiac beriberi)
- Hypothermia
- Peripheral neuropathy (paresthesias, especially distal lower extremities — dry beriberi)
- Vestibular dysfunction (without hearing loss)
- Coma
Korsakoff's Psychosis
- Usually develops as a consequence of untreated or inadequately treated WE
- Anterograde > retrograde amnesia (disproportionate to other cognitive functions)
- Confabulation (often spontaneous)
- Confusion, disorientation, apathy
- Lack of insight into deficits
- Largely irreversible
Differential Diagnosis
- Ethanol toxicity
- Alcohol use disorder
- Alcohol withdrawal
- Electrolyte/acid-base disorder
Vitamin deficiencies
- Vitamin A deficiency
- Vitamin B deficiencies
- Vitamin B1 deficiency (Thiamine)
- Vitamin B3 deficiency (Pellagra)
- Vitamin B9 deficiency (Folate)
- Vitamin B7 deficiency (Biotin)
- Vitamin B12 deficiency
- Vitamin C deficiency (Scurvy)
- Vitamin D deficiency (Rickets)
- Vitamin E deficiency
- Vitamin K deficiency
- Zinc deficiency
- Other diagnoses to consider:
- Stroke/cerebellar infarction (can mimic entire triad — ophthalmoplegia, ataxia, AMS)
- Hepatic encephalopathy
- Hypoglycemia
- Sepsis-associated encephalopathy
- Meningitis/encephalitis
- Metronidazole-induced encephalopathy (similar MRI findings; can coexist in malnourished patients on metronidazole)
- Creutzfeldt-Jakob disease (CJD — may have similar thalamic/basal ganglia signal changes on MRI, but spares mammillary bodies)
- Carbon monoxide poisoning
- Central pontine myelinolysis
- Delirium tremens
Evaluation
Workup
- WE is a clinical diagnosis — do NOT delay treatment for workup
- Labs (to exclude alternative diagnoses and identify co-morbid conditions):
- BMP— electrolytes, glucose, renal function, hepatic function
- CBC
- Magnesium level — critical; hypomagnesemia causes resistance to thiamine therapy
- Lactate — may be elevated (thiamine is a cofactor for pyruvate dehydrogenase)
- Blood alcohol level
- Serum thiamine level (whole blood thiamine preferred over serum/plasma):
- Draw before administering thiamine if possible, but never delay treatment to obtain
- Normal range generally 70-180 nmol/L, but sensitivity and specificity are poorly defined
- A normal thiamine level does NOT exclude WE[3]
- Other labs as clinically indicated: TSH, ammonia, lipase, toxicology screen, blood cultures
- Consider lumbar puncture if meningitis/encephalitis suspected — CSF in WKS typically shows normal or mildly elevated protein without pleocytosis
Imaging
- CT head: sensitivity only ~13% for WE; primary role is to exclude other pathology (hemorrhage, mass, infarct)[4]
- MRI brain (best imaging modality if obtained):
- Sensitivity ~53%, specificity ~93%, positive predictive value ~89%
- MRI is better at confirming the diagnosis than ruling it out
- A normal MRI does NOT exclude WE — do not withhold treatment based on normal imaging
- Classic findings: bilateral, symmetric T2/FLAIR hyperintensities in:
- Mammillary bodies (most distinctive finding; contrast enhancement may be pathognomonic)
- Periventricular/medial thalamus
- Periaqueductal gray matter
- Tectal plate
- Cerebellar vermis (atypical but recognized)
- DWI may show restricted diffusion (helps differentiate vasogenic vs cytotoxic edema)
- Findings may normalize within days of starting thiamine therapy
- Sensitivity ~53%, specificity ~93%, positive predictive value ~89%
- Communicate suspected diagnosis to radiologists so protocols optimized for mammillary bodies, thalami, and periaqueductal region are used
Diagnosis
- Clinical diagnosis — maintain high index of suspicion
- Caine criteria (operational diagnostic criteria; ~85% sensitive when ≥2 present)[5]:
- Nutritional deficiency (any state, not just alcoholism)
- Ocular findings (ophthalmoplegia, nystagmus)
- Cerebellar dysfunction (ataxia)
- Altered mental status or mild memory impairment
- Per EFNS guidelines, clinical diagnosis of WE in alcoholics requires at least 2 of the following[6]:
- Dietary deficiencies
- Ocular findings (ophthalmoplegia, nystagmus)
- Cerebellar dysfunction (ataxia)
- Mental status change or mild memory impairment
Management
If you suspect, then treat! Confirming diagnosis is difficult, treatment is low risk and effective, and morbidity/mortality is high if untreated
Acute Treatment
- Thiamine — IV administration is critical; oral absorption is unreliable in at-risk patients
- Royal College of Physicians / UK guideline (widely adopted):
- 500 mg IV over 30 min TID x 2-3 days → then 250 mg IV/IM once daily x 3-5 days → then 100 mg PO daily until patient no longer at risk
- EFNS guideline:
- 200 mg IV TID (diluted in 100 mL NS or D5W, infused over 30 min)
- 100 mg/day (e.g., banana bag dose) is likely insufficient — especially in patients with alcohol use disorder
- Thiamine has a short half-life (~96 min); multiple daily doses are more effective than once-daily dosing
- Overall safety of thiamine is very good; anaphylaxis risk with IV thiamine is rare
- Royal College of Physicians / UK guideline (widely adopted):
Key Principles
- Give thiamine BEFORE glucose in any at-risk patient requiring dextrose
- Glucose without thiamine can precipitate or worsen WE by driving remaining thiamine intracellularly
- If both are urgently needed (e.g., symptomatic hypoglycemia), give them simultaneously — do not withhold glucose to wait for thiamine
- Give magnesium
- Magnesium is a cofactor for thiamine-dependent enzymes
- Hypomagnesemia may cause resistance to thiamine therapy
- Replete magnesium early and aggressively
- Replete other vitamins/electrolytes as indicated (folate, multivitamin, pyridoxine)
- Monitor for refeeding syndrome in severely malnourished patients
- Treatment response can take days to weeks; lack of immediate improvement does not exclude WE
Treatment Response (Expected Timeline)
- Oculomotor dysfunction: often begins improving within hours to days
- Confusion/encephalopathy: may take days to weeks
- Ataxia: slowest to improve; may be permanent
- Korsakoff psychosis: largely irreversible once established
Common Pitfalls
| Pitfall | Correct Approach |
|---|---|
| Believing WE only affects alcoholics | Any nutritionally deficient state can cause WE — consider post-bariatric surgery, cancer, hyperemesis, critical illness |
| Waiting for the complete classic triad | Triad present in only ~10%; any component + risk factor should prompt treatment |
| Using 100 mg IV thiamine (banana bag) as treatment dose | 100 mg is prophylactic, not therapeutic; treatment requires 200-500 mg IV TID |
| Relying on labs/imaging to confirm before treating | Clinical diagnosis; normal thiamine levels and normal MRI do NOT exclude WE |
| Withholding glucose to wait for thiamine | If hypoglycemia is symptomatic, give both simultaneously; do not delay glucose |
| Forgetting to check/replete magnesium | Hypomagnesemia impairs thiamine utilization; always co-replete |
| Confusing WE with cerebellar stroke | Both present with ophthalmoplegia, ataxia, AMS — always consider WE in differential |
Disposition
- Admit (inpatient medicine or neurology service)
- Ensures continued IV thiamine and magnesium administration
- Observation for development of Korsakoff syndrome
- Evaluation for cardiovascular beriberi
- Address underlying cause of thiamine deficiency
- <25% of patients show full recovery, ~50% show partial recovery, the remainder show no response despite treatment[7]
- ~80% of patients with untreated WE develop Korsakoff syndrome
- Refer patients with alcohol use disorder to cessation programs; monitor for alcohol withdrawal
Prevention
- Give parenteral thiamine to all at-risk patients presenting to the ED — do not wait for symptoms
- After bariatric surgery: follow thiamine status for at least 6 months; supplement parenterally as needed
Vitamin Prophylaxis for Chronic alcoholics
- At risk for thiamine deficiency, but no symptoms: thiamine 100mg PO q day
- Give multivitamin PO; patient at risk for other vitamin deficiencies
Banana bag
The majority of chronic alcoholics do NOT require a banana bag[8][9]
- Thiamine 100mg IV
- Folate 1mg IV (cheaper PO)
- Multivitamin 1 tab IV (cheaper PO)
- Magnesium sulfate 2mg IV
- Normal saline as needed for hydration
See Also
- Ethanol toxicity
- Alcohol use disorder
- Alcohol withdrawal
- Electrolyte/acid-base disorder
External Links
- Emergency Care BC: Wernicke's Encephalopathy Diagnosis and Treatment
- EMCrit IBCC: Thiamine Deficiency and Wernicke Encephalopathy
- StatPearls: Wernicke Encephalopathy
References
- ↑ Donnino MW, Vega J, Miller J, Walsh M. Myths and misconceptions of Wernicke's encephalopathy: what every emergency physician should know. Ann Emerg Med. 2007;50(6):715-21.
- ↑ Sinha S, Kataria A, Kolla BP, et al. Wernicke Encephalopathy-Clinical Pearls. Mayo Clin Proc. 2019;94(6):1065-1072.
- ↑ Ono K, Hayano S, Kashima M. Wernicke encephalopathy: limitations in a laboratory and radiological diagnosis. BMJ Case Rep. 2023;16(12):e254786.
- ↑ Medscape. Wernicke Encephalopathy Workup. Available at: https://emedicine.medscape.com/article/794583-workup
- ↑ Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry. 1997;62(1):51-60.
- ↑ Galvin R, Bråthen G, Ivashynka A, et al. EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol. 2010;17(12):1408-18.
- ↑ https://www.alz.org/alzheimers-dementia/what-is-dementia/types-of-dementia/korsakoff-syndrome
- ↑ Krishel, S, et al. Intravenous Vitamins for Alcoholics in the Emergency Department: A Review. The Journal of Emergency Medicine. 1998; 16(3):419–424.
- ↑ Li, SF, et al. Vitamin deficiencies in acutely intoxicated patients in the ED. The American Journal of Emergency Medicine. 2008; 26(7):792–795.
